Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
OPINION
Corporate America Is Sitting on $5 Trillion of M&A Firepower
By Brian Sozzi
Feb 13, 2018 7:30 PM EST
MERGERS AND ACQUISITIONS
Stock Market Drop Not Seen Dampening Healthcare Deal Activity
By Armie Margaret Lee
Feb 8, 2018 6:48 PM EST
STOCKS
Biotech, pharma stocks tumble amid big market sell-off
By Armie Margaret Lee
Feb 5, 2018 4:30 PM EST
MERGERS AND ACQUISITIONS
Why 2018 will be better for biotech deals than 2017
By Armie Margaret Lee
Jan 25, 2018 7:15 PM EST
MERGERS AND ACQUISITIONS
Celgene says Juno, Impact deals won't be its last
By Armie Margaret Lee
Jan 25, 2018 3:22 PM EST
STOCKS
S&P 500 Will Be Gripped by Classic Investor Euphoria This Year in Surge to 3000
By Brian Sozzi
Jan 23, 2018 10:52 AM EST
OPINION
Immunotherapy M&A In Focus as Celgene Buys Juno; Good, Bad of Activism--ICYMI
By Michael Brown
Jan 22, 2018 7:23 PM EST
MARKETS
Dow, S&P 500 and Nasdaq Hit New Records as Senate Reaches Deal to End Shutdown
By Joseph Woelfel
Jan 22, 2018 4:12 PM EST
VIDEO
Video: Jim Cramer on the Eagles, Celgene, Juno Therapeutics and Netflix
By Jim Cramer
Jan 22, 2018 12:48 PM EST
STOCKS
Immunotherapy stocks power higher on Celgene-Juno deal
By Armie Margaret Lee
Jan 22, 2018 12:03 PM EST
VIDEO
Video: Jim Cramer Reacts to Celgene's Plans to Acquire Juno Therapeutics
By Jim Cramer
Jan 22, 2018 11:45 AM EST
MARKETS
Dow, S&P 500 and Nasdaq Shake Off Government Shutdown to Trade Higher
By Joseph Woelfel
Jan 22, 2018 10:17 AM EST
VIDEO
A Government Shutdown Won't Crush Stock Market, a New England Patriots Win Will
By Brian Sozzi
Jan 22, 2018 8:48 AM EST
STOCKS
Will the Government Shutdown Kill the Mind-Blowing Bull Market?
By Brian Sozzi
Jan 22, 2018 8:04 AM EST
MERGERS AND ACQUISITIONS
Celgene Makes $9 Billion Cancer Treatment Play for Juno Therapeutics
By Martin Baccardax
Jan 22, 2018 7:59 AM EST
FUTURES
Shutdown Enters Day 3, Sanofi Buys Bioverativ - 5 Things You Must Know Before the Market Opens
By Joseph Woelfel
Jan 22, 2018 6:53 AM EST
MERGERS AND ACQUISITIONS
Celgene Could Be Bulking Up Very Fast
By Armie Margaret Lee
Jan 19, 2018 11:22 AM EST
MARKETS
Dow Soars 322 Points to New Record, Surpassing 26,000
By Joseph Woelfel
Jan 17, 2018 4:13 PM EST
MARKETS
Stocks Rebound Despite Financial Sector Weakness
By Joseph Woelfel
Jan 17, 2018 10:18 AM EST
FUTURES
Bank of America, Goldman Sachs, Juno and Ford - 5 Things You Must Know Before the Market Opens
By Joseph Woelfel
Jan 17, 2018 7:42 AM EST
HEALTH
Deal Buzz Sends Juno Shares Soaring
By Armie Margaret Lee
Jan 16, 2018 6:33 PM EST
STOCKS
7 Winners and Losers From Biggest Biotech Conference of 2017
By Tony Owusu
Dec 13, 2017 11:34 AM EST
HOW-TO
How to Make Money Like Amazon Billionaire Jeff Bezos
By Kinsey Grant
Oct 17, 2017 6:01 AM EDT
STOCKS
Intercept Sinks on Safety Issue, One Analyst Says Buy Anyway - Biotech Movers
By Armie Margaret Lee
Sep 22, 2017 12:13 PM EDT
STOCKS
FDA OKs BioCryst's Rapivab for Pediatric Indication - Biotech Movers
By Armie Margaret Lee
Sep 21, 2017 10:10 AM EDT
